Quantity size:
0.2ml
Concentration:
1mg/ml 钙激活钾通道蛋白β1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Potassium channels are a group of ubiquitously expressed proteins that serve numerous functions in excitable and non-excitable cells. One class of integral membrane potassium channels is the large conductance, calcium-activated potassium channel (Maxi K+). Maxi K+ differs from most other potassium channels in that its activation is controlled by both钙激活钾通道蛋白β1抗体 increases in intracellular calcium and by membrane depolarization. Maxi K+ dual activation is possible because of its structure. The core of the channel, which is similar to other potassium channels, is a Maxi K+ alpha homotetramer that contains both a voltage sensor and an intracellular calcium binding domain. In vascular smooth muscle, an auxiliary beta-subunit is found in a 钙激活钾通道蛋白β1抗体1:1 stoichiometry. The beta-subunit exhibits its effect on the Maxi K+ channel by effectively decreasing by 5- to 10- fold the concentration of calcium required to keep the pore open. Maxi K+ beta is the target for possible therapeutics because of its role in blood flow and blood pressure regulation.
Also known as:
MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta钙激活钾通道蛋白β1抗体 subunit. Intracellular calcium regulates the physical association between the alpha and beta subunits; KCMB1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human KCNMB1.
●
Predicted Molecular Weight: 21kDa.
钙激活钾通道蛋白β1抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl313Mu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Ra01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl820Hu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Mu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl353Ge01晚期糖基化终末产物(AGE)多克隆抗体Polyclonal Antibody to Advanced Glycation End Product (AGE)
kl929Hu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Mu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Ra01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl367Hu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Mu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Ra01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl377Hu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Mu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Ra01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl400Hu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl400Mu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl400Ra01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl372Hu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)
kl372Mu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)
kl372Ra01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)
kl217Hu01α1-微球蛋白(α1M)多克隆抗体Polyclonal Antibody to Alpha-1-Microglobulin/Bikunin Precursor (a1M)
kl217Mu01α1-微球蛋白(α1M)多克隆抗体Polyclonal Antibody to Alpha-1-Microglobulin/Bikunin Precursor (a1M)
kl217Ra01α1-微球蛋白(α1M)多克隆抗体Polyclonal Antibody to Alpha-1-Microglobulin/Bikunin Precursor (a1M)
kl050Mu01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话